查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
富血小板血浆市场规模,份额和趋势分析报告，按类型（纯血小板富血浆,白细胞富血浆）,应用（骨科,运动医学,美容外科）,用途,地区和细分市场预测2022-2030
市场调查报告书
商品编码
1114099

富血小板血浆市场规模,份额和趋势分析报告，按类型（纯血小板富血浆,白细胞富血浆）,应用（骨科,运动医学,美容外科）,用途,地区和细分市场预测2022-2030

Platelet Rich Plasma Market Size, Share & Trends Analysis Report By Type (Pure Platelet Rich Plasma, Leukocyte Rich), By Application (Orthopedics, Sports Medicine, Cosmetic Surgery), By End-use, By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

富含血小板的血浆市场增长和趋势

根据 Grand View Research, Inc. 的一份新报告，2022 年至 2030 年，全球富血小板血浆市场规模的复合年增长率将达到 15.11%，到 2030 年将达到 19 亿。预计达到4000万美元。

整容手术的兴起、国内和国际体育赛事数量的增加以及血浆疗法研究的扩大正在推动该行业的发展。此外，基于富血小板血浆 (PRP) 的疗法的研发活动和监管批准是主要的市场驱动力。

目前，使用 PRP 治疗运动损伤、骨科疾病和肌肉骨骼疾病的需求激增。 PRP 提供浓缩剂量的生长因子，可以显着减少癒合所需的时间。 PRP 在再生医学领域也有重要应用，可作为每位患者的定制产品，以加速伤口癒合和修復级联。

富血小板血浆已在整形手术中开发出来，在利用人体自身的自然组织修復过程并改善形态和功能方面取得了可喜的成果。 PRP 疗法的主要优点是易于使用、使用患者细胞进行廉价生产以及几乎没有副作用的风险。然而，治疗耗时且需要多次治疗。它还对皮肤再生、皮肤色素沉着、痤疮疤痕治疗和吸血鬼面部收紧皮肤有效。 PRP 用作毛髮移植补充剂，以帮助形成和维持毛囊。因此，富含血小板的血浆的广泛使用有望推动行业增长。

此外，主要参与者正在实施併购、产品开发和业务扩展等战略举措以进入市场。 2021 年 9 月，Terumo BCT 扩大了在哥斯达黎加的业务，在迦太基的拉利马开设了新的製造工厂，以扩大其在美国的客户群。 2020年2月，EmCyte Inc.收购了拥有 Centrepid 血小板浓缩系统的 Cellmedix Holdings LLC。这扩大了公司的产品组合併提高了市场占有率。

鑑于 COVID-19，由于供应链中断、资源分配限制和患者获取活动受阻，市场经历了重大挫折。然而，到 2021 年 1 月，市场趋于稳定，供需继续正常化，用户和患者重新获得富含血小板的血浆。

富血小板血浆市场报告亮点

按类型划分，纯富含血小板的血浆部分将在 2021 年拥有超过 50.0% 的最大收入份额，原因是其在各个治疗领域的广泛使用以及全球对标籤外使用的需求不断增长。

按应用划分，由于调查 PRP 在骨科各种应用中的研究数量激增，骨科领域在 2021 年占据了市场主导地位。然而，其他领域，如皮肤科、运动医学和溃疡癒合预计在预测期内将以更快的速度增长

医院最终用途部门在 2021 年占最大的收入份额。这可能是由于近年来提供基于 PRP 治疗的医院数量增加以及膝关节骨关节炎病例数量增加所致

由于 RPP 的广泛使用、对基于 PRP 的疗法的认识不断提高以及骨科疾病的发病率不断上升，北美在 2021 年主导了全球市场。

由于整容手术的增加和医疗旅游业的增长，预计亚太地区未来将显着增长。

内容

第一章调查方法及范围

  • 调查方法
  • 调查假设
    • 估计/预测时间表
  • 信息采购
  • 调查方法
  • 信息采购
    • 购买的数据库
    • GVR 内部数据库
    • 辅助信息
    • 初步调查
    • 初步调查的内容
  • 信息或数据分析
    • 富血小板血浆 (PRP) 市场：细分市场收入和增长分析
    • 运动医学市场：细分收入和增长分析
    • 基于富血小板血浆 (PRP) 的溃疡治疗市场：细分市场收入和增长分析
      • 基于富血小板血浆 (PRP) 的溃疡癒合市场：细分定义
      • 不癒合溃疡
      • 糖尿病溃疡
      • 压疮
      • 坏疽性脓皮病
      • 静脉溃疡
    • 数据分析模型
  • 市场製定和验证
  • 型号详情
    • 商品流向分析
      • 方法 1：商品流通方法
      • 方法 2：使用自下而上的方法估算国别市场
  • 市场：CAGR 计算
  • 辅助信息列表
  • 主要信息列表
  • 目的

第 2 章市场定义

第 3 章执行摘要

  • 市场展望
  • 市场概览

第 4 章宿主细胞污染物检测市场变量、趋势和范围

  • 市场趋势和前景
  • 市场细分和范围
  • 市场驱动因素分析
    • 骨科疾病和运动损伤的发病率不断上升
    • 对检测宿主细胞污染进行更严格的监管
    • 扩展富血小板血浆的医疗应用
    • 增加基于 PRP 的伤口癒合的循证研究
  • 市场约束分析
    • 与 PRP 产品相关的高成本
  • 按因素（政法、经济、技术）进行 SWOT 分析
  • 波特五力分析
  • COVID-19 影响分析
  • 绘製渗透率和增长前景

第 5 章富含血小板的血浆市场 - 细分分析，按类型，2018-2030 年（百万美元）

  • 富血小板血浆市场：类型变异分析
  • 纯 PRP
  • 富含白细胞的 Prp
  • 其他

第 6 章富血小板血浆市场 - 细分分析，按应用，2018-2030 年（百万美元）

  • 富血小板血浆：应用变异分析
  • 骨科
  • 运动医学
  • 整容手术
  • 皮肤科
    • 涵盖的场景：美国的医疗保险和医疗补助服务中心
    • 溃疡癒合
      • 静脉溃疡
      • 外伤性溃疡
      • 坏疽性脓皮病溃疡
      • 糖尿病溃疡
      • 营养性溃疡
      • 血管炎性溃疡
    • 其他
  • 眼科
  • 神经外科
  • 普通外科
  • 其他

第 7 章富血小板血浆 (PRP) 市场 - 细分分析，按最终用途，2018-2030 年（百万美元）

  • 富血小板血浆 (PRP)：最终用途变异分析
  • 医院
  • 医务室
  • 其他

第 8 章富血小板血浆 (PRP) 市场细分分析，按地区分列，2018-2030 年（百万美元）

  • 富血小板血浆 (PRP) 市场：区域差异分析
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 西班牙
    • 法国
    • 意大利
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳大利亚
  • 拉丁美洲
    • 巴西
    • 墨西哥
  • 中东和非洲
    • 南非
    • 阿拉伯联合酋长国
    • 沙特阿拉伯

第 9 章公司简介

  • 战略框架
  • 市场参与的分类
  • 公司简介
    • 强生公司
      • 公司简介
      • DePuy 合成
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • Arthrex, Inc.
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • EmCyte 公司
      • 公司简介
      • 产品基准
      • 战略举措
    • DR. PRP AMERICA, LLC
      • 公司简介
      • 产品基准
    • 尤文蒂斯
      • 公司简介
      • 财务表现
      • 产品基准
    • 泰尔茂公司
      • 公司简介
      • 泰尔茂 BCT 有限公司
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • Zimmer Biomet
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • 史崔克
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • Apex Biologix
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • 细胞生物科学
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
Product Code: GVR-1-68038-869-5

Platelet Rich Plasma Market Growth & Trends:

The global platelet rich plasma market size is expected to reach USD 1.94 billion by 2030, registering a CAGR of 15.11% from 2022 to 2030, according to a new report by Grand View Research, Inc. Rising number of cosmetic surgeries, increasing national and international sporting events, and extending research in plasma-based therapies are fueling the industry growth. Furthermore, R&D activities and regulatory approvals of platelet rich plasma (PRP) based treatments are key market drivers.

Currently, there has been an upsurge in demand for use of PRP in the treatment of sports injuries, orthopedic disorders, and musculoskeletal conditions. It concentrates on growth factors and can significantly reduce healing time. PRP also finds major application in the regenerative medicine field and serves as a custom product for each patient speeding up wound healing and repair cascade.

Platelet rich plasma has evolved in plastic surgery with promising results to utilize the body's own natural tissue repair process to achieve improved form and function. The characteristics such as ease of use, inexpensive to produce utilizing patient's cells, and little or no risk of adverse reactions are the main advantages offered by PRP therapies. However, treatment has been time consuming and requires multiple sessions. Moreover, it helps in skin rejuvenation, skin pigmentation, treating acne scars, and skin tightening during vampire facials. PRP is used as a supplement for hair transplant, which helps in the formation and maintenance of hair follicles. Thus, the widespread uses of platelet rich plasma are anticipated to fuel industry growth.

Furthermore, the key players are implementing strategic initiatives such as mergers and acquisitions, product development, and business expansions to enter the market. In September 2021, Terumo BCT expanded its presence in Costa Rica with the opening of a new manufacturing facility in La Lima, Cartago, with the view to expand its customer base in the U.S. In February 2020, EmCyte Co. acquired Cellmedix Holdings LLC, with its Centrepid platelet concentrator system. This expanded the company's product portfolio and improved its market presence.

In light of COVID-19, the market witnessed a significant setback due to supply chain disruption, constraints in resource allocation, and hindrances in patient access activities, among other reasons. However, by January 2021, the market got stabilized and continue to normalize demand and supply, and users and patients regain access to platelet-rich plasma.

Platelet Rich Plasma Market Report Highlights:

  • By type, the pure platelet-rich plasma segment held the largest revenue share of over 50.0% in 2021 due to its widespread use across various therapeutic areas and rising demand for its off-label uses worldwide
  • By application, the orthopedics segment dominated the market in 2021 due to an upsurge in the number of research studies to investigate PRP across various applications in orthopedics. However, other segments such as dermatology, sports medicine, and ulcer healing are expected to grow at a faster rate over the forecast period
  • The hospitals end-use segment held the largest revenue share in 2021. This can be attributed to an increase in the number of hospitals delivering PRP-based therapies and rising number of knee osteoarthritis cases in recent years
  • North America dominated the global market in 2021 due to wider applications of RPP, rising awareness about PRP-based treatments, and increasing number of orthopedics incidences
  • Asia Pacific is expected to grow considerably in the future owing to rising number of cosmetic surgeries and growing medical tourism industry

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Research Methodology
  • 1.2 Research Assumptions
    • 1.2.1 Estimates and Forecast Timeline
  • 1.3 Information Procurement
  • 1.4 Research Methodology
  • 1.5 Information Procurement
    • 1.5.1 Purchased Database
    • 1.5.2 GVR's Internal Database
    • 1.5.3 Secondary Sources
    • 1.5.4 Primary Research
    • 1.5.5 Details of Primary Research
  • 1.6 Information or Data Analysis
    • 1.6.1 Platelet Rich Plasma (PRP) Market: segment revenue and growth analysis
    • 1.6.2 sports medicine market: segment revenue and growth analysis
    • 1.6.3 Platelet Rich Plasma (PRP)-based ulcer healing Market: segment revenue and growth analysis
      • 1.6.3.1 Platelet Rich Plasma (PRP)-based ulcer healing Market: segment definition
      • 1.6.3.1.1 Non-Healing Ulcers
      • 1.6.3.1.1.1 Diabetic Ulcers
      • 1.6.3.1.1.2 Pressure Ulcers
      • 1.6.3.1.1.3 Pyoderma gangrenosum
      • 1.6.3.1.1.4 Venous ulcers
    • 1.6.4 Data Analysis Models
  • 1.7 Market Formulation & Validation
  • 1.8 Model Details
    • 1.8.1 Commodity Flow Analysis
      • 1.8.1.1 Approach 1: Commodity Flow Approach
      • 1.8.1.2 Approach 2: Country-wise market estimation using bottom-up approach
  • 1.9 Market: CAGR Calculation
  • 1.10 List of Secondary Sources
  • 1.11 List of Primary Sources
  • 1.12 Objectives
    • 1.12.1 Objective 1
    • 1.12.2 Objective 2

Chapter 2 Market Definitions

Chapter 3 Executive Summary

  • 3.1 Market Outlook
  • 3.2 Market Summary

Chapter 4 Host Cell Contaminant Testing Market Variables, Trends & Scope

  • 4.1 Market Trends & Outlook
  • 4.2 Market Segmentation & Scope
  • 4.3 Market Driver Analysis
    • 4.3.1 Rise In The Incidence Of Orthopedic Disorders And Sports Injuries
    • 4.3.2 Increasing Regulatory Focus On Host Cell Contaminant Detection
    • 4.3.3 extending Medical Applications Of Platelet Rich Plasma
    • 4.3.4 Increasing Number Of Evidence-Based Studies For Prp-Based Wound Healing
  • 4.4 Market Restraint Analysis
    • 4.4.1 high Costs Associated With Prp Products
  • 4.5 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
  • 4.6 Porter's Five Forces Analysis
  • 4.7 COVID-19 Impact Analysis
  • 4.8 Penetration & Growth Prospect Mapping

Chapter 5 Platelet Rich Plasma Market - Segment Analysis, by Type, 2018 - 2030 (USD Million)

  • 5.1 Platelet Rich PlasmaMarket: Type Movement Analysis
  • 5.2 Pure PRP
    • 5.2.1 Pure Prpmarket Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.3 leukocyte Rich Prp
    • 5.3.1 leukocyte Rich Prpmarket Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.4 Others
    • 5.4.1 Other Type Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6 Platelet Rich Plasma market - Segment Analysis, By Application, 2018 - 2030 (USD Million)

  • 6.1 platelet Rich Plasmamarket: Application Movement Analysis
  • 6.2 Orthopedics
    • 6.2.1 Orthopedics Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.3 Sports Medicine
    • 6.3.1 Sport Medicine market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.4 Cosmetic Surgery
    • 6.4.1 Platelet Rich Plasma (Prp) Market Estimates And Forecast For Cosmetic Surgery, 2018 - 2030
  • 6.5 Dermatology
    • 6.5.1 Coverage Scenario: U.S. Centers For Medicare & Medicaid Services
    • 6.5.2 Platelet Rich Plasma (Prp) Market Estimates And Forecast For Dermatology, 2018 - 2030
    • 6.5.3 Ulcer healing
      • 6.5.3.1 Platelet Rich Plasma (PRP) Market estimates and forecast for ulcer healing, 2018 - 2030
      • 6.5.3.2 Venous ulcers
      • 6.5.3.2.1 Platelet Rich Plasma (PRP) Market estimates and forecast for venous ulcers, 2018 - 2030
      • 6.5.3.3 Traumatic ulcers
      • 6.5.3.3.1 Platelet Rich Plasma (PRP) Market estimates and forecast for traumatic ulcers, 2018 - 2030
      • 6.5.3.4 Pyoderma gangrenosum ulcers
      • 6.5.3.4.1 Platelet Rich Plasma (PRP) Market estimates and forecast for pyoderma gangrenosum ulcers, 2018 - 2030
      • 6.5.3.5 Diabetic ulcers
      • 6.5.3.5.1 Platelet Rich Plasma (PRP) Market estimates and forecast for diabetic ulcers, 2018 - 2030
      • 6.5.3.6 Trophic ulcers
      • 6.5.3.6.1 Platelet Rich Plasma (PRP) Market estimates and forecast for trophic ulcers, 2018 - 2030
      • 6.5.3.7 Vasculitic ulcers
      • 6.5.3.7.1 Platelet Rich Plasma (PRP) Market estimates and forecast for vasculitic ulcers, 2018 - 2030
    • 6.5.4 Others
      • 6.5.4.1 Platelet Rich Plasma (PRP) Market estimates and forecast for others, 2018 - 2030
  • 6.6 Ophthalmic Surgery
    • 6.6.1 Platelet Rich Plasma (Prp) Market Estimates And Forecast For Ophthalmic Surgery, 2018 - 2030
  • 6.7 Neurosurgery
    • 6.7.1 Platelet Rich Plasma (Prp) Market Estimates And Forecast For Neurosurgery, 2018 - 2030
  • 6.8 General Surgery
    • 6.8.1 Platelet Rich Plasma (Prp) Market Estimates And Forecast For General Surgery, 2018 - 2030
  • 6.9 Others
    • 6.9.1 Platelet Rich Plasma (Prp) Market Estimates And Forecast For Others, 2018 - 2030

Chapter 7 Platelet Rich Plasma (PRP) Market - Segment Analysis, by End-use, 2018 - 2030 (USD Million)

  • 7.1 Platelet Rich Plasma (PRP): End-use Movement Analysis
  • 7.2 Hospitals
    • 7.2.1 Hospitals market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.3 Clinics
    • 7.3.1 Clinics market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.4 Others
    • 7.4.1 Others market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 8 Platelet Rich Plasma (PRP) Market - Segment Analysis, by Region, 2018 - 2030 (USD Million)

  • 8.1 Platelet Rich Plasma (PRP) Market: Regional Movement Analysis
  • 8.2 North America
    • 8.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.2 U.S.
      • 8.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.3 Canada
      • 8.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.3 Europe
    • 8.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.2 Germany
      • 8.3.2.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.3 U.K.
      • 8.3.3.1 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.4 Spain
      • 8.3.4.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.5 France
      • 8.3.5.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.6 Italy
      • 8.3.6.1 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.2 Japan
      • 8.4.2.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.3 China
      • 8.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.4 India
      • 8.4.4.1 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.5 South Korea
      • 8.4.5.1 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.6 Australia
      • 8.4.6.1 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.5 Latin America
    • 8.5.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.5.2 Brazil
      • 8.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.5.3 Mexico
      • 8.5.3.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.6 Middle East And Africa
    • 8.6.1 Middle-East And Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.6.2 South Africa
      • 8.6.2.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.6.3 UAE
      • 8.6.3.1 UAE Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.6.4 Saudi Arabia
      • 8.6.4.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9 Company Profile

  • 9.1 Strategy Framework
  • 9.2 Market Participation Categorization
  • 9.3 Company Profiles
    • 9.3.1 Johnson & Johnson
      • 9.3.1.1 Company overview
      • 9.3.1.2 DePuy Synthes
      • 9.3.1.2.1 Company overview
      • 9.3.1.3 Financial Performance
      • 9.3.1.4 Product benchmarking
      • 9.3.1.5 Strategic initiatives
    • 9.3.2 Arthrex, Inc.
      • 9.3.2.1 Company overview
      • 9.3.2.2 Financial Performance
      • 9.3.2.3 Product benchmarking
      • 9.3.2.4 Strategic initiatives
    • 9.3.3 EmCyte Corporation
      • 9.3.3.1 Company overview
      • 9.3.3.2 Product benchmarking
      • 9.3.3.3 Strategic initiatives
    • 9.3.4 DR. PRP AMERICA, LLC
      • 9.3.4.1 Company overview
      • 9.3.4.2 Product benchmarking
    • 9.3.5 Juventix
      • 9.3.5.1 Company overview
      • 9.3.5.2 Financial Performance
      • 9.3.5.3 Product benchmarking
    • 9.3.6 Terumo Corporation
      • 9.3.6.1 Company overview
      • 9.3.6.2 TERUMO BCT, INC.
      • 9.3.6.2.1 Company overview
      • 9.3.6.3 Financial Performance
      • 9.3.6.4 Product benchmarking
      • 9.3.6.5 Strategic initiatives
    • 9.3.7 Zimmer Biomet
      • 9.3.7.1 Company overview
      • 9.3.7.2 Financial Performance
      • 9.3.7.3 Product benchmarking
      • 9.3.7.4 Strategic initiatives
    • 9.3.8 Stryker
      • 9.3.8.1 Company overview
      • 9.3.8.2 Financial Performance
      • 9.3.8.3 Product benchmarking
      • 9.3.8.4 Strategic initiatives
    • 9.3.9 Apex Biologix
      • 9.3.9.1 Company overview
      • 9.3.9.2 Financial Performance
      • 9.3.9.3 Product benchmarking
      • 9.3.9.4 Strategic initiatives
    • 9.3.10 Celling Biosciences
      • 9.3.10.1 Company overview
      • 9.3.10.2 Financial Performance
      • 9.3.10.3 Product benchmarking
      • 9.3.10.4 Strategic initiatives

List of Tables

  • Table 1 Global Platelet Rich Plasma (PRP) Market, By Region, 2018 - 2030 (USD Million)
  • Table 2 Global Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 3 Global Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 4 Global Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 5 North America Platelet Rich Plasma (PRP) Market, By Country, 2018 - 2030 (USD Million)
  • Table 6 North America Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 7 North America Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 8 North America Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 9 U.S. Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 10 U.S. Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 11 U.S. Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 12 Canada Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 13 Canada Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 14 Canada Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 15 Europe Platelet Rich Plasma (PRP) Market, By Country, 2018 - 2030 (USD Million)
  • Table 16 Europe Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 17 Europe Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 18 Europe Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 19 U.K. Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 20 U.K. Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 21 U.K. Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 22 Germany Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 23 Germany Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 24 Germany Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 25 France Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 26 France Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 27 France Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 28 Italy Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 29 Italy Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 30 Italy Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 31 Spain Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 32 Spain Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 33 Spain Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific Platelet Rich Plasma (PRP) Market, By Country, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 37 Asia Pacific Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 38 Japan Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 39 Japan Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 40 Japan Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 41 China Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 42 China Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 43 China Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 44 India Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 45 India Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 46 India Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 47 Australia Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 48 Australia Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 49 Australia Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 50 South Korea Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 51 South Korea Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 52 South Korea Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 53 Latin America Platelet Rich Plasma (PRP) Market, By Country, 2018 - 2030 (USD Million)
  • Table 54 Latin America Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 55 Latin America Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 56 Latin America Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 57 Brazil Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 58 Brazil Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 59 Brazil Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 60 Mexico Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 61 Mexico Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 62 Mexico Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 63 Middle East & Africa Platelet Rich Plasma (PRP) Market, By Country, 2018 - 2030 (USD Million)
  • Table 64 Middle East & Africa Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 65 Middle East & Africa Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 66 Middle East & Africa Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 67 South Africa Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 68 South Africa Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 69 South Africa Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 70 Saudi Arabia Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 71 Saudi Arabia Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 72 Saudi Arabia Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 73 UAE Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 74 UAE Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 75 UAE Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 PRP segment revenue modeling
  • Fig. 5 Sports medicine market segment revenue modeling
  • Fig. 6 PRP-based ulcer healing market: Segment revenue modeling
  • Fig. 7 Commercial viability and research base for PRP-based treatment of non-healing ulcer
  • Fig. 8 Market research approaches
  • Fig. 9 Value chain-based sizing & forecasting
  • Fig. 10 QFD modeling for market share assessment
  • Fig. 11 Market formulation & validation
  • Fig. 12 Platelet rich plasma (PRP) market snapshot, 2021 (USD Million)
  • Fig. 13 Platelet rich plasma (PRP) market segmentation
  • Fig. 14 Market driver relevance analysis (Current & future impact)
  • Fig. 15 Prevalence rate of arthritis in the U.S. adults, diagnosed and projected cases
  • Fig. 16 Incidence of arthritis in U.S., by age
  • Fig. 17 Incidence of osteoarthritis in the UK, 2019 (%)
  • Fig. 18 Benefits of PRP treatment in cosmetic facial procedures
  • Fig. 19 Common cosmetic surgical procedures in 2019
  • Fig. 20 Cosmetic plastic demographic data in 2019
  • Fig. 21 Common minimal invasive procedures in 2019, U.S.
  • Fig. 22 Number of customers for cosmetic surgery in China (Million)
  • Fig. 23 Number of cosmetic procedures in 2016 (Thousand)
  • Fig. 24 Market restraint relevance analysis (Current & future impact)
  • Fig. 25 Market opportunity relevance analysis (Current & future impact)
  • Fig. 26 Penetration and growth prospect mapping, by Application, 2021
  • Fig. 27 Platelet rich plasma (PRP) market SWOT analysis
  • Fig. 28 Platelet rich plasma (PRP) market Porter's five forces analysis
  • Fig. 29 Platelet rich plasma (PRP) market: Type outlook and key takeaways
  • Fig. 30 Platelet rich plasma (PRP) market: Type movement analysis
  • Fig. 31 Pure PRP market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Leukocyte rich PRP market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 PRP market estimates and forecast for others, 2018 - 2030 (USD Million)
  • Fig. 34 Platelet rich plasma (PRP) market: Application outlook and key takeaways
  • Fig. 35 Platelet rich plasma (PRP) market: Application movement analysis
  • Fig. 36 Platelet rich plasma (PRP) market estimates and forecast for orthopedics, 2018 - 2030 (USD Million)
  • Fig. 37 Platelet rich plasma (PRP) market estimates and forecast for sports medicine, 2018 - 2030 (USD Million)
  • Fig. 38 Platelet rich plasma (PRP) Market estimates and forecast for cosmetic surgery, 2018 - 2030 (USD Million)
  • Fig. 39 Platelet rich plasma (PRP) market estimates and forecast for dermatology, 2018 - 2030 (USD Million)
  • Fig. 40 Reduction in the mean surface area of non-healing ulcers through 5 weeks
  • Fig. 41 Distribution of demographic parameter in patients with non-healing ulcers
  • Fig. 42 Categorization of studies based on types of ulcers
  • Fig. 43 Platelet rich plasma (PRP) market estimates and forecast for ulcer healing, 2018 - 2030 (USD Million)
  • Fig. 44 Meta-analysis of lower extremity venous ulcers
  • Fig. 45 Platelet rich plasma (PRP) market estimates and forecast for venous ulcers, 2018 - 2030 (USD Million)
  • Fig. 46 Platelet rich plasma (PRP) market estimates and forecast for traumatic ulcers, 2018 - 2030 (USD Million)
  • Fig. 47 Platelet rich plasma (PRP) market estimates and forecast for pyoderma gangrenosum ulcers, 2018 - 2030 (USD Million)
  • Fig. 48 Results obtained for individuals treated with PRP-Part A
  • Fig. 49 Results obtained for individuals treated with PRP-Part B
  • Fig. 50 Results obtained for individuals treated with PRP-Part C
  • Fig. 51 Key details of the meta-analysis performed on lower extremity diabetic ulcers
  • Fig. 52 Platelet rich plasma (PRP) market estimates and forecast for diabetic ulcers, 2018 - 2030
  • Fig. 53 Reduction in the surface area of trophic ulcers
  • Fig. 54 Reduction in the surface area of trophic ulcers
  • Fig. 55 Platelet rich plasma (PRP) market estimates and forecast for trophic ulcers, 2018 - 2030
  • Fig. 56 Potential of autologous PRP in the management of non-healing vasculitic ulcers
  • Fig. 57 Platelet rich plasma (PRP) Market estimates and forecast for vasculitic ulcers, 2018 - 2030 (USD Million)
  • Fig. 58 Platelet rich plasma (PRP) Market estimates and forecast for others, 2018 - 2030 (USD Million)
  • Fig. 59 Platelet rich plasma (PRP) market estimates and forecast for ophthalmic surgery, 2018 - 2030 (USD Million)
  • Fig. 60 Platelet rich plasma (PRP) market estimates and forecast for neurosurgery, 2018 - 2030 (USD Million)
  • Fig. 61 Platelet rich plasma (PRP) market estimates and forecast for general surgery, 2018 - 2030
  • Fig. 62 Platelet rich plasma (PRP) market estimates and forecast for others, 2018 - 2030 (USD Million)
  • Fig. 63 Platelet rich plasma (PRP) market: End-use outlook and key takeaways
  • Fig. 64 Platelet rich plasma (PRP) market: End-use movement analysis
  • Fig. 65 Platelet rich plasma (PRP) market for hospitals, 2018 - 2030 (USD Million)
  • Fig. 66 Platelet rich plasma (PRP) market for clinics, 2018 - 2030 (USD Million)
  • Fig. 67 Platelet rich plasma (PRP) market for others, 2018 - 2030 (USD Million)
  • Fig. 68 Platelet rich plasma (PRP) market: Regional outlook and key takeaways
  • Fig. 69 Platelet rich plasma (PRP) market: Regional movement analysis
  • Fig. 70 Strategy framework
  • Fig. 71 Market participation categorization